Emphasizing the role of exosomal ULBPs, others have also revealed that tumor cells release exosomal ULBP3 which is more potent for NKG2D downregulation compared to soluble ULBP2, limiting cytotoxic activity of NK cells [102]. Here, KLRK1 is linked to neoplasm.